Surgical Assessment and Intraoperative Management of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer

Annals of Thoracic Surgery

Volumn 84, Issue 3, 2007, Pages 1059-1065

  Whitson, Bryan A ^a   Groth, Shawn S ^a   Maddaus, Michael A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACCURACY; ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; HUMAN; INTRAOPERATIVE PERIOD; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SURVIVAL TIME;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; MEDIASTINOSCOPY; MEDIASTINUM; NEOPLASM STAGING; THORACIC SURGERY, VIDEO-ASSISTED;

EID: 34548018048     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.04.032     Document Type: Review

References (54)

1. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest 111 (1997) 1710-1717
2. Naruke T., Goya T., Tsuchiya R., and Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 96 (1988) 440-447
3. Little A.G., Rusch V.W., Bonner J.A., et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg 80 (2005) 2051-2056
4. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
5. Cerfolio R.J., Ojha B., Bryant A.S., Raghuveer V., Mountz J.M., and Bartoluci A.A. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 78 (2004) 1017-1023
6. Halpern B.S., Schiepers C., Weber W.A., et al. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest 128 (2005) 2289-2297
7. Magnani P., Carretta A., Rizzo G., et al. FDG/PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients. J Cardiovasc Surg (Torino) 40 (1999) 741-748
8. D'Cunha J., Herndon II J.E., Herzan D.L., et al. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from Cancer and Leukemia Group B 9761, a prospective trial. Lung Cancer 48 (2005) 241-246
9. Coughlin M., Deslauriers J., Beaulieu M., et al. Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer. Ann Thorac Surg 40 (1985) 556-560
10. Cybulsky I.J., and Bennett W.F. Mediastinoscopy as a routine outpatient procedure. Ann Thorac Surg 58 (1994) 176-178
11. Hammoud Z.T., Anderson R.C., Meyers B.F., et al. The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg 118 (1999) 894-899
12. Luke W.P., Pearson F.G., Todd T.R., Patterson G.A., and Cooper J.D. Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung. J Thorac Cardiovasc Surg 91 (1986) 53-56
13. Patterson G.A., Ginsberg R.J., Poon P.Y., et al. A prospective evaluation of magnetic resonance imaging, computed tomography, and mediastinoscopy in the preoperative assessment of mediastinal node status in bronchogenic carcinoma. J Thorac Cardiovasc Surg 94 (1987) 679-684
14. Pauwels M., Van Schil P., De Backer W., Van den Brande F., and Eyskens E. Repeat mediastinoscopy in the staging of lung cancer. Eur J Cardiothorac Surg 14 (1998) 271-273
15. Ginsberg R.J., Rice T.W., Goldberg M., Waters P.F., and Schmocker B.J. Extended cervical mediastinoscopy. A single staging procedure for bronchogenic carcinoma of the left upper lobe. J Thorac Cardiovasc Surg 94 (1987) 673-678
16. Kuzdzal J., Zielinski M., Papla B., et al. Transcervical extended mediastinal lymphadenectomy-the new operative technique and early results in lung cancer staging. Eur J Cardiothorac Surg 27 (2005) 384-390
17. Kuzdzal J., Zielinski M., Papla B., et al. The transcervical extended mediastinal lymphadenectomy versus cervical mediastinoscopy in non-small cell lung cancer staging. Eur J Cardiothorac Surg 31 (2007) 88-94
18. Liptay M.J., Grondin S.C., Fry W.A., et al. Intraoperative sentinel lymph node mapping in non-small-cell lung cancer improves detection of micrometastases. J Clin Oncol 20 (2002) 1984-1988
19. Little A.G., DeHoyos A., Kirgan D.M., Arcomano T.R., and Murray K.D. Intraoperative lymphatic mapping for non-small cell lung cancer: the sentinel node technique. J Thorac Cardiovasc Surg 117 (1999) 220-224
20. Rzyman W., Hagen O.M., Dziadziuszko R., et al. Intraoperative, radio-guided sentinel lymph node mapping in 110 nonsmall cell lung cancer patients. Ann Thorac Surg 82 (2006) 237-242
21. Rzyman W., Hagen O.M., Dziadziuszko R., et al. Blue-dye intraoperative sentinel lymph node mapping in early non-small cell lung cancer. Eur J Surg Oncol 32 (2006) 462-465
22. Sugi K., Kaneda Y., Sudoh M., Sakano H., and Hamano K. Effect of radioisotope sentinel node mapping in patients with cT1 N0 M0 lung cancer. J Thorac Cardiovasc Surg 126 (2003) 568-573
23. Schenk D.A., Chambers S.L., Derdak S., et al. Comparison of the Wang 19-gauge and 22-gauge needles in the mediastinal staging of lung cancer. Am Rev Respir Dis 147 (1993) 1251-1258
24. Herth F., Becker H.D., and Ernst A. Conventional vs endobronchial ultrasound-guided transbronchial needle aspiration: a randomized trial. Chest 125 (2004) 322-325
25. Annema J.T., Versteegh M.I., Veselic M., et al. Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA 294 (2005) 931-936
26. Feinstein A.R., Sosin D.M., and Wells C.K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312 (1985) 1604-1608
27. Allen M.S., Darling G.E., Pechet T.T., et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 81 (2006) 1013-1019 discussion 1019-20
28. Okada M., Sakamoto T., Yuki T., Mimura T., Miyoshi K., and Tsubota N. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. Ann Thorac Surg 81 (2006) 1028-1032
29. Doddoli C., Aragon A., Barlesi F., et al. Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?. Eur J Cardiothorac Surg 27 (2005) 680-685
30. Lardinois D., Suter H., Hakki H., Rousson V., Betticher D., and Ris H.B. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg 80 (2005) 268-274
31. Gajra A., Newman N., Gamble G.P., Kohman L.J., and Graziano S.L. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 21 (2003) 1029-1034
32. Oda M., Watanabe Y., Shimizu J., et al. Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: the role of systematic nodal dissection. Lung Cancer 22 (1998) 23-30
33. Sugi K., Nawata K., Fujita N., et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg 22 (1998) 290-294 discussion 294-5
34. Keller S.M., Adak S., Wagner H., and Johnson D.H. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg 70 (2000) 358-365 discussion 365-6
35. Keller S.M., Adak S., Wagner H., et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med 343 (2000) 1217-1222
36. Wu Y., Huang Z.F., Wang S.Y., Yang X.N., and Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 36 (2002) 1-6
37. Izbicki J.R., Thetter O., Habekost M., et al. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. Br J Surg 81 (1994) 229-235
38. Ichinose Y., Yano T., Asoh H., Yokoyama H., Yoshino I., and Katsuda Y. Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage. J Thorac Cardiovasc Surg 110 (1995) 601-605
39. Asamura H., Nakayama H., Kondo H., Tsuchiya R., and Naruke T. Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg 117 (1999) 1102-1111
40. Casali C., Stefani A., Natali P., Rossi G., and Morandi U. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases. Eur J Cardiothorac Surg 28 (2005) 33-38
41. Riquet M., Assouad J., Bagan P., et al. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann Thorac Surg 79 (2005) 225-233
42. Misthos P., Sepsas E., Athanassiadi K., Kakaris S., and Skottis I. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer. Eur J Cardiothorac Surg 25 (2004) 502-508
43. Keller S.M., Vangel M.G., Wagner H., et al. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. J Thorac Cardiovasc Surg 128 (2004) 130-137
44. Prenzel K.L., Monig S.P., Sinning J.M., et al. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer. J Surg Oncol 82 (2003) 256-260
45. Yoshino I., Yokoyama H., Yano T., et al. Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer. Ann Thorac Surg 62 (1996) 1021-1025
46. Watanabe A., Koyanagi T., Obama T., et al. Assessment of node dissection for clinical stage I primary lung cancer by VATS. Eur J Cardiothorac Surg 27 (2005) 745-752
47. Watanabe A., Koyanagi T., Ohsawa H., et al. Systematic node dissection by VATS is not inferior to that through an open thoracotomy: a comparative clinicopathologic retrospective study. Surgery 138 (2005) 510-517
48. Ettinger D.S., Bepler G., Bueno R., et al. Non-small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 4 (2006) 548-582
49. Henschke C.I., Wisnivesky J.P., Yankelevitz D.F., and Miettinen O.S. Small stage I cancers of the lung: genuineness and curability. Lung Cancer 39 (2003) 327-330
50. Ludwig M.S., Goodman M., Miller D.L., and Johnstone P.A. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest 128 (2005) 1545-1550
51. Wisnivesky J.P., Henschke C., McGinn T., and Iannuzzi M.C. Prognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosis. Lung Cancer 49 (2005) 181-186
52. Ginsberg R.J. Resection of non-small cell lung cancer: how much and by what route. Chest 112 (1997) 203S-205S
53. Sedrakyan A., Van Der Meulen J., O'Byrne K., Prendiville J., Hill J., and Treasure T. Postoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 128 (2004) 414-419
54. Tubiana M. Radiotherapy in non-small cell lung cancer. An overview. Chest 96 (1989) 85S-87S